rendered its award requiring EXAT to compensate the Company for damages as follows: 1) Damages, together with interest, amounting to Baht 1,048.2 Million, and default interest under the Second Stage
value per day in 1Q19, which was Bt114.85mn, was higher than 4Q18, which was Bt113.50mn. The details of total revenue are as follows. 1) Income from rendering top-up service for prepaid phone and other
product segment has been re-classified as follows: Revenue contribution Revenue by segment (THB mn) In this quarter, the Company reported a consolidated operating revenue of THB 689mn, an increase of 149.3
products that has not yet the competitor. And has been researching and good testing. 4. Details of acquired assets Details of the BS Myco Biotech Company Limited as follows: 4.1 General information
important details of cash flow were as follows: 2.1.1 Cash and cash equivalent of Bt1,315.9 million which cash flow summarized for the period of six months of 2019 were below;- - The Group’s net cash from
management discussion and analysis for the 2nd Quarter of 2019 and the six months period ending 30 June 2019, as follows: Financial Performance Analysis Revenues Revenues 2nd Quarter (April-June) 2018 2019 THB
periodically and quite frequently for the operators’ IT system improvement. The details of total revenue are as follows. 1) Income from rendering top-up service for prepaid phone and other online services
as follows: Management Discussion and Analysis For the 6 Months Period Ended 30 June 2019 Summary of Performance Sales Revenue For the period of six months ended 30 June 2018 and 2019, the Company
Withya Public Company Limited ("Company") would like to describe and analyze the financial position and operating results for quarter 2-2019 are summarized as follows. Performance Analysis For the Quarter
summarized as follows. Performance Analysis For the Quarter 2-2019, the Company and its subsidiaries had total revenue of 268.56 million baht, a decrease of 104.65 million baht or 28.04 percent compared to the